PDCD1 and cancer: The peripheral blood of cancer patients, particularly those with a high disease burden, is enriched for CD8+ T cells expressing checkpoint proteins indicating exhaustion and immunotherapy resistance, including PD-1, TIM3, TIGIT, and LAG3 (3–7).